Contrave recalls
Contrave products have been recalled 2 times, most recently on 14 Nov 2018. The recalling company is usually Orexigen Therapeutics. The most common reason is packaging defects.
Total recalls2since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 14 Nov 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 2 100%
Why contrave is recalled
Companies
Product types
By year
All contrave recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Contrave (naltrexone HCl and bupropion HCl) recalledContrave | Orexigen Therapeutics | Packaging Defects | CA |
| Drug | CLASS III | Contrave (naltrexone HCl and bupropion HCl) recalledContrave | Orexigen Therapeutics | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.